ADDRESS-2 is a partner in the Type 1 Diabetes UK Immunotherapy Research Consortium

    Finding new and better treatments for type 1 diabetest1duk-logo-website

T1DUK aims to:

  • Develop and conduct new trials in type 1 diabetes
  • Make the UK one of the best places to run trials
  • Learn as much as we can about every participant in every trial

Find out more about T1DUK